+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cannabidiol Market by Type, Distribution Channel, End-use - Global Forecast 2025-2030- Product Image
Cannabidiol Market by Type, Distribution Channel, End-use - Global Forecast 2025-2030- Product Image
Sale

Cannabidiol Market by Type, Distribution Channel, End-use - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6010635
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cannabidiol Market grew from USD 4.40 billion in 2023 to USD 5.14 billion in 2024. It is expected to continue growing at a CAGR of 16.87%, reaching USD 13.11 billion by 2030.

Cannabidiol (CBD) is a non-psychoactive compound derived from the cannabis plant, predominantly used for its potential therapeutic benefits, including pain relief, anti-inflammatory effects, and anxiety reduction. Its scope spans various industries, such as pharmaceuticals, cosmetics, food and beverages, and wellness products. The necessity for CBD arises from its growing recognition as a natural remedy to treat a wide range of health conditions, from chronic pain and epilepsy to skincare issues and mental health disorders. Its end-use scope is vast, including products like oils, creams, capsules, edibles, and beverages, appealing to health-conscious consumers and those seeking alternatives to traditional medications. The market is driven by increasing consumer awareness about health and wellness, evolving regulatory landscapes favoring legalization, and growing research highlighting CBD's therapeutic benefits. Key growth factors include the rising prevalence of chronic diseases, expanding use in beauty and skincare products, and advancements in extraction and formulation techniques. Opportunities exist in the untapped markets of developing countries and in niche applications such as pet care and functional foods. Businesses can capitalize on these by focusing on high-quality product innovations, rigorous research, and collaborations with research institutions to validate efficacy claims. However, market growth is challenged by regulatory uncertainties, quality control issues due to the unregulated nature of some markets, and public misconceptions regarding cannabis-related products. Innovation areas that show promise include nano-emulsification for better bioavailability, advanced delivery systems, and tailored formulations for specific health conditions. The CBD market is characterized by rapid growth and high competition, demanding that companies maintain stringent compliance with local laws and prioritize transparent consumer education. Practical recommendations include establishing strong supply chain partnerships, investing in consumer education initiatives to demystify CBD benefits and safety, and leveraging digital marketing to enhance brand visibility and consumer trust.

Understanding Market Dynamics in the Cannabidiol Market

The Cannabidiol Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Growing acceptance and use of products due to government approvals
    • Increasing customer inclination towards natural or herbal remedies/products
    • Increasing awareness of healing properties of cannabidiol
  • Market Restraints
    • Risk of side-effects such as dry mouth, diarrhea, reduced appetite
  • Market Opportunities
    • Rising demand from medical and pharmaceutical industry
    • Boosting product sales though alliances with health and wellness retailers
  • Market Challenges
    • Lack of awareness and standardization

Exploring Porter’s Five Forces for the Cannabidiol Market

Porter’s Five Forces framework further strengthens the insights of the Cannabidiol Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Cannabidiol Market

External macro-environmental factors deeply influence the performance of the Cannabidiol Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Cannabidiol Market

The Cannabidiol Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Cannabidiol Market

The Cannabidiol Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Cannabidiol Market

The Cannabidiol Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cannabidiol Market, highlighting leading vendors and their innovative profiles. These include Aphria, Inc, Aurora Cannabis, Cannbit Pharmaceuticals, Cannoid, LLC, Canopy Growth Corporation, CBD American Shaman, Curaleaf Holdings Inc., CV Sciences, Inc, Elixinol LLC, Endoca BV, Folium Biosciences, Freedom Leaf, Inc, GL Brands, Inc., High Tide, Inc., Isodiol International, Inc., Jazz Pharmaceuticals PLC, Kazmira LLC, Maricann, Inc., Medical Marijuana, Inc., Nuleaf Naturals LLC, Organigram Holding, Inc., Pharmahemp d.o.o., The Valens Company, Tilray Brands, Inc., and VIVO Cannabis Inc.

Market Segmentation & Coverage

This research report categorizes the Cannabidiol Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Type
    • Hemp
    • Marijuana
  • Distribution Channel
    • B2B
    • B2C
      • Hospital Pharmacies
      • Online
      • Retail Stores
  • End-use
    • Medical
      • Cancer
      • Chronic Pain
      • Mental Disorders
    • Personal Use
    • Pharmaceuticals
    • Wellness
      • Food & Beverages
      • Nutraceuticals
      • Personal Care & Cosmetics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing acceptance and use of products due to government approvals
5.1.1.2. Increasing customer inclination towards natural or herbal remedies/products
5.1.1.3. Increasing awareness of healing properties of cannabidiol
5.1.2. Restraints
5.1.2.1. Risk of side-effects such as dry mouth, diarrhea, reduced appetite
5.1.3. Opportunities
5.1.3.1. Rising demand from medical and pharmaceutical industry
5.1.3.2. Boosting product sales though alliances with health and wellness retailers
5.1.4. Challenges
5.1.4.1. Lack of awareness and standardization
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Cannabidiol Market, by Type
6.1. Introduction
6.2. Hemp
6.3. Marijuana
7. Cannabidiol Market, by Distribution Channel
7.1. Introduction
7.2. B2B
7.3. B2C
7.3.1. Hospital Pharmacies
7.3.2. Online
7.3.3. Retail Stores
8. Cannabidiol Market, by End-use
8.1. Introduction
8.2. Medical
8.2.1. Cancer
8.2.2. Chronic Pain
8.2.3. Mental Disorders
8.3. Personal Use
8.4. Pharmaceuticals
8.5. Wellness
8.5.1. Food & Beverages
8.5.2. Nutraceuticals
8.5.3. Personal Care & Cosmetics
9. Americas Cannabidiol Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Cannabidiol Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Cannabidiol Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
LIST OF FIGURES
FIGURE 1. CANNABIDIOL MARKET RESEARCH PROCESS
FIGURE 2. CANNABIDIOL MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CANNABIDIOL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CANNABIDIOL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CANNABIDIOL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CANNABIDIOL MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL CANNABIDIOL MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL CANNABIDIOL MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL CANNABIDIOL MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS CANNABIDIOL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS CANNABIDIOL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES CANNABIDIOL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES CANNABIDIOL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC CANNABIDIOL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC CANNABIDIOL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CANNABIDIOL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CANNABIDIOL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. CANNABIDIOL MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. CANNABIDIOL MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
TABLE 1. CANNABIDIOL MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CANNABIDIOL MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CANNABIDIOL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CANNABIDIOL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CANNABIDIOL MARKET DYNAMICS
TABLE 7. GLOBAL CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CANNABIDIOL MARKET SIZE, BY HEMP, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CANNABIDIOL MARKET SIZE, BY MARIJUANA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CANNABIDIOL MARKET SIZE, BY B2B, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CANNABIDIOL MARKET SIZE, BY B2C, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CANNABIDIOL MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CANNABIDIOL MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CANNABIDIOL MARKET SIZE, BY RETAIL STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CANNABIDIOL MARKET SIZE, BY MEDICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CANNABIDIOL MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CANNABIDIOL MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CANNABIDIOL MARKET SIZE, BY MENTAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CANNABIDIOL MARKET SIZE, BY PERSONAL USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CANNABIDIOL MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CANNABIDIOL MARKET SIZE, BY WELLNESS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CANNABIDIOL MARKET SIZE, BY FOOD & BEVERAGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CANNABIDIOL MARKET SIZE, BY NUTRACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CANNABIDIOL MARKET SIZE, BY PERSONAL CARE & COSMETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS CANNABIDIOL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 49. CANADA CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. CANADA CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. CANADA CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 52. CANADA CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 53. CANADA CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 54. CANADA CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 55. MEXICO CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. MEXICO CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 57. MEXICO CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 58. MEXICO CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 59. MEXICO CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 60. MEXICO CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES CANNABIDIOL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 74. ASIA-PACIFIC CANNABIDIOL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. AUSTRALIA CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. AUSTRALIA CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 78. AUSTRALIA CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 79. AUSTRALIA CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 80. AUSTRALIA CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 81. CHINA CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. CHINA CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 83. CHINA CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 84. CHINA CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 85. CHINA CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 86. CHINA CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 87. INDIA CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. INDIA CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. INDIA CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 90. INDIA CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 91. INDIA CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 92. INDIA CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 93. INDONESIA CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. INDONESIA CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. INDONESIA CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 96. INDONESIA CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 97. INDONESIA CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 98. INDONESIA CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 99. JAPAN CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. JAPAN CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. JAPAN CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 102. JAPAN CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 103. JAPAN CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 104. JAPAN CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 105. MALAYSIA CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. MALAYSIA CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. MALAYSIA CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 108. MALAYSIA CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 109. MALAYSIA CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 110. MALAYSIA CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 111. PHILIPPINES CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. PHILIPPINES CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. PHILIPPINES CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 114. PHILIPPINES CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 115. PHILIPPINES CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 116. PHILIPPINES CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 117. SINGAPORE CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. SINGAPORE CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 119. SINGAPORE CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 120. SINGAPORE CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 121. SINGAPORE CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 122. SINGAPORE CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 123. SOUTH KOREA CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. SOUTH KOREA CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. SOUTH KOREA CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 126. SOUTH KOREA CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 127. SOUTH KOREA CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 128. SOUTH KOREA CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 129. TAIWAN CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. TAIWAN CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 131. TAIWAN CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 132. TAIWAN CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 133. TAIWAN CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 134. TAIWAN CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 135. THAILAND CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. THAILAND CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. THAILAND CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 138. THAILAND CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 139. THAILAND CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 140. THAILAND CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 141. VIETNAM CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 142. VIETNAM CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. VIETNAM CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 144. VIETNAM CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 145. VIETNAM CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 146. VIETNAM CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA CANNABIDIOL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 154. DENMARK CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 155. DENMARK CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 156. DENMARK CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 157. DENMARK CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 158. DENMARK CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 159. DENMARK CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 160. EGYPT CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 161. EGYPT CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. EGYPT CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 163. EGYPT CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 164. EGYPT CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 165. EGYPT CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 166. FINLAND CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 167. FINLAND CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. FINLAND CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 169. FINLAND CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 170. FINLAND CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 171. FINLAND CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 172. FRANCE CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 173. FRANCE CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. FRANCE CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 175. FRANCE CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 176. FRANCE CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 177. FRANCE CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 178. GERMANY CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 179. GERMANY CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. GERMANY CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 181. GERMANY CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 182. GERMANY CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 183. GERMANY CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 184. ISRAEL CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 185. ISRAEL CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. ISRAEL CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 187. ISRAEL CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 188. ISRAEL CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 189. ISRAEL CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 190. ITALY CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 191. ITALY CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. ITALY CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 193. ITALY CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 194. ITALY CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 195. ITALY CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 202. NIGERIA CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 203. NIGERIA CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 204. NIGERIA CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 208. NORWAY CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 209. NORWAY CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 210. NORWAY CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 211. NORWAY CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 212. NORWAY CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 213. NORWAY CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 214. POLAND CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 215. POLAND CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 216. POLAND CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 217. POLAND CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 218. POLAND CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 219. POLAND CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 220. QATAR CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 221. QATAR CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. QATAR CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 223. QATAR CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 224. QATAR CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 225. QATAR CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 244. SPAIN CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 245. SPAIN CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 246. SPAIN CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 247. SPAIN CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 248. SPAIN CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 249. SPAIN CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 262. TURKEY CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 263. TURKEY CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 264. TURKEY CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 265. TURKEY CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 266. TURKEY CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 267. TURKEY CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 274. UNITED KINGDOM CANNABIDIOL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM CANNABIDIOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 276. UNITED KINGDOM CANNABIDIOL MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM CANNABIDIOL MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 278. UNITED KINGDOM CANNABIDIOL MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM CANNABIDIOL MARKET SIZE, BY WELLNESS, 2018-2030 (USD MILLION)
TABLE 280. CANNABIDIOL MARKET SHARE, BY KEY PLAYER, 2023
TABLE 281. CANNABIDIOL MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Cannabidiol market, which are profiled in this report, include:
  • Aphria, Inc
  • Aurora Cannabis
  • Cannbit Pharmaceuticals
  • Cannoid, LLC
  • Canopy Growth Corporation
  • CBD American Shaman
  • Curaleaf Holdings Inc.
  • CV Sciences, Inc
  • Elixinol LLC
  • Endoca BV
  • Folium Biosciences
  • Freedom Leaf, Inc
  • GL Brands, Inc.
  • High Tide, Inc.
  • Isodiol International, Inc.
  • Jazz Pharmaceuticals PLC
  • Kazmira LLC
  • Maricann, Inc.
  • Medical Marijuana, Inc.
  • Nuleaf Naturals LLC
  • Organigram Holding, Inc.
  • Pharmahemp d.o.o.
  • The Valens Company
  • Tilray Brands, Inc.
  • VIVO Cannabis Inc

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages191
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 5.14 Billion
Forecasted Market Value ( USD ) by 2030 $ 13.11 Billion
Compound Annual Growth Rate16.8%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Cannabidiol Market Size, Share & Trends Analysis Report by Source Type (Hemp, Marijuana), Sales Type (B2B, B2C), End-use (Medical, Personal Use), Region, and Segment Forecasts, 2024-2030 - Product Image

Cannabidiol Market Size, Share & Trends Analysis Report by Source Type (Hemp, Marijuana), Sales Type (B2B, B2C), End-use (Medical, Personal Use), Region, and Segment Forecasts, 2024-2030

  • Report
  • 150 Pages
  • Global
From
Cannabidiol Oil Market by Product, Source, Distribution Channel, Application - Global Forecast 2025-2030 - Product Image

Cannabidiol Oil Market by Product, Source, Distribution Channel, Application - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Cannabidiol - Global Strategic Business Report - Product Image

Cannabidiol - Global Strategic Business Report

  • Report
  • 96 Pages
  • Global
From
Cannabidiol Global Market Report 2024 - Product Image

Cannabidiol Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Cannabidiol (CBD) Market Outlook Report: Industry Size, Competition, Trends and Growth Opportunities by Region, YoY Forecasts from 2024 to 2031 - Product Image

Cannabidiol (CBD) Market Outlook Report: Industry Size, Competition, Trends and Growth Opportunities by Region, YoY Forecasts from 2024 to 2031

  • Report
  • 144 Pages
  • Global
From

About the Cannabidiol Market

Cannabidiol (CBD) is a cannabinoid found in the Cannabis sativa plant. It is a non-psychoactive compound that has been studied for its potential therapeutic effects on the central nervous system (CNS). CBD has been found to have anti-inflammatory, antioxidant, and neuroprotective properties, and has been studied for its potential to treat a variety of neurological disorders, including epilepsy, anxiety, depression, and Parkinson's disease. CBD is increasingly being used as an alternative to traditional CNS drugs, such as benzodiazepines and opioids. It is being studied for its potential to reduce the side effects of traditional medications, as well as its potential to treat a variety of neurological conditions. The CBD market is growing rapidly, with a variety of products available, including oils, tinctures, edibles, and topical creams. Companies in the market include Charlotte's Web, Elixinol, and Endoca. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.